Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole QD and BID in Japanese Patients with Atopic Dermatitis
NCT03954158Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Pfizer. Primary endpoint: Change From Baseline in Total Sign Score at Day 15. Started Jun 2019; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03954158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03954158.